Inicio
Markets
Charts & Ideas
Algo
Noticias
Store
Corredores
Descargar
Calendario económico
Señales Comerciales
WebTerminal
Pulse
/
para buscar: @user, $symbol, ...
Buscar
Entrada
Crear una cuenta
Español
English
Русский
中文
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
PCRX
#2101
Pacira BioSciences, Inc. Common Stock
21.910
0
-5.88%
Sector:
Básica:
Profit Currency:
Rango diario
Rango anual
Cambio diario
-5.88%
Monthly Change
+10.54%
6 month change
+0.37%
Cambio anual
+0.37%
Cierres anteriores
23.280
0
Open
21.910
0
Bid
Ask
Low
21.910
0
High
21.910
0
Volumen
171
Markets
Acciones
Atención Sanitaria
PCRX
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
46.17 M
46.28 M
46.3 M
44.93 M
43.02 M
40.49 M
—
Valuation ratios
Enterprise value
448.94 M
595.07 M
867.06 M
773.41 M
961.07 M
889.33 M
3.49 B
Price to earnings ratio
-7.72
-8.76
-11.09
-8.72
52.59
161.75
194.53
Price to sales ratio
1.09
119.65
2.3
2.12
2.21
—
—
Price to cash flow ratio
3.69
4.6
6.71
8.21
8.28
7.67
30.88
Price to book ratio
0.22
1.12
0.37
0.36
0.38
1.68
2.79
Enterprise value to EBITDA ratio
11.94
-1.67
-2.17
-1.88
-3.67
—
—
Profitability ratios
Return on assets %
0.06
0.01
0
-0
-0
-0.01
-0.01
Return on equity %
0.12
0.02
0.01
-0.01
-0.01
-0.01
-0.02
Return on invested capital %
19.89
10.31
0.43
-1.72
1.48
0.68
0.87
Gross margin %
76.95
21.9 K
79.69
77.43
80.91
79.53
317.56
Operating margin %
33.59
-13.5 K
1.18
4.69
3.54
1.19
10.6
EBITDA margin %
-72.67
192.01 K
15.42
19.59
15.4
-27.24
23.17
Net margin %
52.05
-8 765.57
2.85
-2.64
-2.37
-4.09
-6.26
Liquidity ratios
Quick ratio
1.89
2
1.99
1.91
3.78
3.28
10.96
Current ratio
2.25
2.4
2.41
2.38
5.26
4.54
14.6
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.11
-0
0.11
0.12
0.13
0.15
0.5
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
0.25
0.25
0.24
0.25
0.29
0.29
1.07
Long term debt to total equity ratio
0.51
0.49
0.48
0.5
0.52
0.54
2.03
Per share metrics
Operating cash flow per share
1.17
0.72
0.76
0.26
1.33
0.97
3.32
EBIT per share
-3.09
-8.06
0.11
0.18
0.14
-1.66
-1.24
EBITDA per share
-2.65
-7.6
0.56
0.77
0.6
-1.19
0.75
Total debt per share
—
—
—
—
—
—
—
Cash per share
9.81
10.48
10.61
9.72
5.39
5.29
31.01
Net current asset value per share
14.91
16.11
16.33
16.26
12.31
12.17
57.06
Tangible book value per share
6.68
7.62
7.35
6.87
7.1
6.77
28.08
Working capital per share
8.29
9.41
9.57
9.43
9.96
9.49
38.45
Book value per share
16.2
16.83
17.16
16.52
15.9
15.39
64.98
Noticias
Pacira BioSciences, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:PCRX) 2026-02-27
Pacira BioSciences Q4 Earnings and Revenues Miss Estimates, Stock Down
Resultados de Pacira en la mira ante amenaza de genéricos a EXPAREL
Resultados de Pacira en la mira ante amenaza genérica a EXPAREL
Pacira BioSciences: Mispriced On Generic Risks That Are Years Away (NASDAQ:PCRX)
Vicepresidenta de Pacira BioSciences vende acciones por 83.000 dólares
Vicepresidenta de Pacira BioSciences vende acciones por $83,000
Pacira BioSciences SVP Lauren Riker sells $83k in stock
Directivo de Pacira BioSciences vende acciones por 269.000 dólares
Directivo de Pacira BioSciences vende acciones por $269 mil
Pacira BioSciences officer Williams sells $269k in shares
5 Drug/Biotech Stocks Likely to Outperform Q4 Earnings Estimates